All In Biotech

Drug Trial Radar · NCT06074380

Non Inferiority Trial Investigating Surfactants Administered Via MIST

Last checked: Nov 20, 2026Latest source record: Aug 7, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 262 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

262

Planned (sponsor's estimate)

Start

Jan 1, 2024

Primary completion

Dec 30, 2025

Study completion Dec 1, 2027

Sponsor

Lead sponsor
Endeavor HealthAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Oct 10, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, up to 48 hours
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

RESEARCH DESIGN Multicenter, randomized, controlled trial. RECRUITMENT Entry criteria Preterm infants 28-35 6/7 weeks' gestation and less than 48 hours of age who have a clinical diagnosis of respiratory distress syndrome. Infants who are on NCPAP and FiO2 ≥0.30 will randomized to curosurf or infasurf via MIST. Exclusion criteria Infants will be excluded if there is a congenital anomaly or an alternative cause for respiratory distress. Babies who require emergent intubation will not be enrolled in the interventions. Parental Consent will be obtained prior to randomization.

Conditions

  • Respiratory Distress Syndrome

Interventions

  • MIST surfactantDrug

    Surfactant will be given via MIST while neonate is on CPAP

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of infants requiring Endotracheal IntubationTime frame: 7 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Northshore University Healthsystem

    Evanston, Illinois · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.